fda glp-1 warning letters october 2025 Sends to More Than 50 Compounders and Manufacturers FDA in Flux — February

Readers are encouraged to verify all details directly with Gala GLP-1 and their healthcare provider before making decisions

As the potential uses of these drugs expand, such as with recent approvals to prevent heart attacks and strokes in adults with cardiovascular disease who are overweight, the high cost and increased demand for these drugs may increase health spending

Fineman MS, Mace KF, Diamant M, et al

The creation of a separate MDL for GLP-1 vision loss claims underscores how seriously the courts are taking these allegations

The new mask leverages a fully flexible frame technology to cope with frequent nocturnal movement, according to ResMed

doi: 10.1152/ajprenal.00394.2015 42 SalineMBadertscherLWolterMLauRGunnarssonAJacsoTet al